A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Brand Name :
N/A
Synonyms :
methanesulfonyl fluoride
Class :
Cholinergic Agents, Neurotransmitter Agents
Dosage Forms & StrengthsÂ
3.6 mg, 7.2 mg, 10.8 mg MSF were given orally to 27 healthy volunteers (between the ages 50 to 72 years) in a randomised, placebo-controlled phase I research. The individuals got the same dosages three times a week for two weeks after a single dose phase and a one-week wash-out period
Safety and efficacy were not established
Refer to the adult dosing regimen
Actions and spectrum:Â
Action:Â
Spectrum:Â
Frequency not definedÂ
CoughingÂ
difficulty breathingÂ
wheezingÂ
NauseaÂ
diarrheaÂ
VomitingÂ
Cardiovascular effectsÂ
Muscle weaknessÂ
CNS effectsÂ
CancerÂ
Neurological damage
Black Box Warning:Â
There is no specific black box warning associated with methanesulfonyl fluoride.
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Comorbidities:Â
Pregnancy consideration: pregnancy category: not assignedÂ
Lactation: excreted into human milk: unknown
Pregnancy category:Â
Pharmacology:Â
methanesulfonyl fluoride (MSF) is not typically discussed in the context of pharmacology, as it is not a pharmaceutical agent but rather a chemical reagent used in organic synthesis. As a reagent, MSF is utilized in the creation of mesylates, a class of compounds formed by the reaction of MSF with alcohols. The mesylation reaction involves replacing a hydroxyl group with the mesyl (methanesulfonyl) group.
This process is valuable in organic chemistry for protecting and modifying functional groups in various organic molecules. MSF’s pharmacological profile is not characterized in terms of therapeutic effects or interactions with biological systems, as it is primarily employed as a tool in laboratory synthesis rather than for medical applications. Safety considerations revolve around its reactivity, toxicity, and corrosive nature, emphasizing the importance of careful handling in well-ventilated environments with proper protective measures.Â
Pharmacodynamics:Â
MSF is a chemical reagent used in organic synthesis, particularly in the formation of mesylates. Its pharmacological profile is not characterized by interactions with specific receptors or physiological systems in the body.Â
Pharmacokinetics:Â
Administration:Â
methanesulfonyl fluoride (MSF) is not administered in the traditional sense, as it is not a pharmaceutical drug intended for medical use. Instead, it is a chemical reagent primarily used in laboratory settings for organic synthesis. When working with MSF in the laboratory, its application involves specific techniques in chemical reactions rather than administration to a biological system.
The handling of MSF typically follows established laboratory protocols for the safe use of reactive and potentially hazardous chemicals. MSF is often used in controlled reactions within a laboratory setting. It is added to reaction vessels as part of the synthesis process, typically involving the formation of mesylates.Â
Patient information leafletÂ
Generic Name: methanesulfonyl fluorideÂ
Pronounced: (Meth – ane – sul – fonyl – fluoride)
Why do we use methanesulfonyl fluoride?Â
methanesulfonyl fluoride (MSF) is a chemical reagent with various applications in organic synthesis. Its primary function is as a reagent in chemical reactions, particularly in the creation of mesylates. MSF is widely used for mesylation reactions, where it reacts with alcohols to form mesylates (methanesulfonates). This reaction involves substituting a hydroxyl group in an organic molecule with a mesyl group.
Mesylates are valuable intermediates in organic synthesis. The mesylation reaction is often employed for the protection of hydroxyl groups in organic molecules. By converting hydroxyl groups to mesylates, chemists can temporarily block the reactivity of these groups, allowing for selective transformations in a multi-step synthesis.Â